Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC

NCT06033118 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Combined Hepatocellular Cholangiocarcinoma

Interventions

DRUG: gemcitabine ,oxaliplatin,anlotinib,Sintilimab

Sponsor

Sichuan University